Ploidy variation as an adaptive mechanism in human pathogenic fungi

Seminars in Cell and Developmental Biology

Volumn 24, Issue 4, 2013, Pages 339-346

  Morrow, Carl A ^a   Fraser, James A ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Aneuploidy; Cancer; Candida albicans; Cryptococcus neoformans; Pathogenic fungi; Polyploidy

Indexed keywords

ANEUPLOIDY; CANCER CELL; CANDIDA ALBICANS; CRYPTOCOCCUS NEOFORMANS; FUNGUS; HUMAN; LIVER CELL; MUTATION; MYCOSIS; NONHUMAN; POLYPLOIDY; REVIEW; STRESS;

CANDIDA ALBICANS; FILOBASIDIELLA NEOFORMANS; FUNGI;

EID: 84876719128     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2013.01.008     Document Type: Review

References (99)

1. Zolan M.E. Chromosome-length polymorphism in fungi. Microbiological Reviews 1995, 59:686-698.
2. Goodwin S.B., M'Barek S.B., Dhillon B., Wittenberg A.H., Crane C.F., Hane J.K., et al. Finished genome of the fungal wheat pathogen Mycosphaerella graminicola reveals dispensome structure, chromosome plasticity, and stealth pathogenesis. PLoS Genetics 2011, 7:e1002070.
3. Ma L.J., van der Does H.C., Borkovich K.A., Coleman J.J., Daboussi M.J., Di Pietro A., et al. Comparative genomics reveals mobile pathogenicity chromosomes in Fusarium. Nature 2010, 464:367-373.
4. Querol A., Bond U. The complex and dynamic genomes of industrial yeasts. FEMS Microbiology Letters 2009, 293:1-10.
5. Selmecki A., Gerami-Nejad M., Paulson C., Forche A., Berman J. An isochromosome confers drug resistance in vivo by amplification of two genes, ERG11 and TAC1. Molecular Microbiology 2008, 68:624-641.
6. Hu G., Liu I., Sham A., Stajich J.E., Dietrich F.S., Kronstad J.W. Comparative hybridization reveals extensive genome variation in the AIDS-associated pathogen Cryptococcus neoformans. Genome Biology 2008, 9:R41.
7. Morrow C.A., Lee I.R., Chow E.W., Ormerod K.L., Goldinger A., Byrnes E.J., et al. A unique chromosomal rearrangement in the Cryptococcus neoformans var. grubii type strain enhances key phenotypes associated with virulence. mBio 2012, 3.
8. Fries B.C., Casadevall A. Serial isolates of Cryptococcus neoformans from patients with AIDS differ in virulence for mice. Journal of Infectious Diseases 1998, 178:1761-1766.
9. Cowen L.E., Sanglard D., Calabrese D., Sirjusingh C., Anderson J.B., Kohn L.M. Evolution of drug resistance in experimental populations of Candida albicans. Journal of Bacteriology 2000, 182:1515-1522.
10. Morrow C.A., Fraser J.A. Sexual reproduction and dimorphism in the pathogenic basidiomycetes. FEMS Yeast Research 2009, 9:161-177.
11. Dunham M.J., Badrane H., Ferea T., Adams J., Brown P.O., Rosenzweig F., et al. Characteristic genome rearrangements in experimental evolution of Saccharomyces cerevisiae. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:16144-16149.
12. Gresham D., Desai M.M., Tucker C.M., Jenq H.T., Pai D.A., Ward A., et al. The repertoire and dynamics of evolutionary adaptations to controlled nutrient-limited environments in yeast. PLoS Genetics 2008, 4:e1000303.
13. Foster P.L. Stress-induced mutagenesis in bacteria. Critical Reviews in Biochemistry and Molecular Biology 2007, 42:373-397.
14. Galhardo R.S., Hastings P.J., Rosenberg S.M. Mutation as a stress response and the regulation of evolvability. Critical Reviews in Biochemistry and Molecular Biology 2007, 42:399-435.
15. Rustchenko E. Chromosome instability in Candida albicans. FEMS Yeast Research 2007, 7:2-11.
16. Hull C.M., Johnson A.D. Identification of a mating type-like locus in the asexual pathogenic yeast Candida albicans. Science 1999, 285:1271-1275.
17. Magee B.B., Magee P.T. Induction of mating in Candida albicans by construction of MTLa and MTLα strains. Science 2000, 289:310-313.
18. Alby K., Schaefer D., Bennett R.J. Homothallic and heterothallic mating in the opportunistic pathogen Candida albicans. Nature 2009, 460:890-893.
19. Miller M.G., Johnson A.D. White-opaque switching in Candida albicans is controlled by mating-type locus homeodomain proteins and allows efficient mating. Cell 2002, 110:293-302.
20. Zordan R.E., Miller M.G., Galgoczy D.J., Tuch B.B., Johnson A.D. Interlocking transcriptional feedback loops control white-opaque switching in Candida albicans. PLoS Biology 2007, 5:e256.
21. Hull C.M., Raisner R.M., Johnson A.D. Evidence for mating of the "asexual" yeast Candida albicans in a mammalian host. Science 2000, 289:307-310.
22. Bennett R.J., Johnson A.D. Completion of a parasexual cycle in Candida albicans by induced chromosome loss in tetraploid strains. EMBO Journal 2003, 22:2505-2515.
23. Forche A., Alby K., Schaefer D., Johnson A.D., Berman J., Bennett R.J. The parasexual cycle in Candida albicans provides an alternative pathway to meiosis for the formation of recombinant strains. PLoS Biology 2008, 6:e110.
24. Selmecki A., Forche A., Berman J. Genomic plasticity of the human fungal pathogen Candida albicans. Eukaryotic Cell 2010, 9:991-1008.
25. Forche A., Magee P.T., Selmecki A., Berman J., May G. Evolution in Candida albicans populations during a single passage through a mouse host. Genetics 2009, 182:799-811.
26. Forche A., Abbey D., Pisithkul T., Weinzierl M.A., Ringstrom T., Bruck D., et al. Stress alters rates and types of loss of heterozygosity in Candida albicans. mBio 2011, 2.
27. Quinto-Alemany D., Canerina-Amaro A., Hernandez-Abad L.G., Machin F., Romesberg F.E., Gil-Lamaignere C. Yeasts acquire resistance secondary to antifungal drug treatment by adaptive mutagenesis. PLoS One 2012, 7:e42279.
28. Iwaguchi S.I., Kanbe T., Tohne T., Magee P.T., Suzuki T. High-frequency occurrence of chromosome translocation in a mutant strain of Candida albicans by a suppressor mutation of ploidy shift. Yeast 2000, 16:411-422.
29. Bouchonville K., Forche A., Tang K.E., Selmecki A., Berman J. Aneuploid chromosomes are highly unstable during DNA transformation of Candida albicans. Eukaryotic Cell 2009, 8:1554-1566.
30. Selmecki A.M., Dulmage K., Cowen L.E., Anderson J.B., Berman J. Acquisition of aneuploidy provides increased fitness during the evolution of antifungal drug resistance. PLoS Genetics 2009, 5:e1000705.
31. Janbon G., Sherman F., Rustchenko E. Monosomy of a specific chromosome determines L-sorbose utilization: a novel regulatory mechanism in Candida albicans. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:5150-5155.
32. Rustchenko E.P., Howard D.H., Sherman F. Chromosomal alterations of Candida albicans are associated with the gain and loss of assimilating functions. Journal of Bacteriology 1994, 176:3231-3241.
33. Legrand M., Forche A., Selmecki A., Chan C., Kirkpatrick D.T., Berman J. Haplotype mapping of a diploid non-meiotic organism using existing and induced aneuploidies. PLoS Genetics 2008, 4:e1.
34. Arbour M., Epp E., Hogues H., Sellam A., Lacroix C., Rauceo J., et al. Widespread occurrence of chromosomal aneuploidy following the routine production of Candida albicans mutants. FEMS Yeast Research 2009, 9:1070-1077.
35. Selmecki A., Bergmann S., Berman J. Comparative genome hybridization reveals widespread aneuploidy in Candida albicans laboratory strains. Molecular Microbiology 2005, 55:1553-1565.
36. Berman J., Hadany L. Does stress induce (para)sex?, Implications for Candida albicans evolution. Trends in Genetics 2012, 28:197-203.
37. Coste A.T., Karababa M., Ischer F., Bille J., Sanglard D. TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2. Eukaryotic Cell 2004, 3:1639-1652.
38. Coste A., Turner V., Ischer F., Morschhauser J., Forche A., Selmecki A., et al. A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans. Genetics 2006, 172:2139-2156.
39. Coste A., Selmecki A., Forche A., Diogo D., Bougnoux M.E., d'Enfert C., et al. Genotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates. Eukaryotic Cell 2007, 6:1889-1904.
40. Marr K.A., Lyons C.N., Ha K., Rustad T.R., White T.C. Inducible azole resistance associated with a heterogeneous phenotype in Candida albicans. Antimicrobial Agents and Chemotherapy 2001, 45:52-59.
41. Marr K.A., Lyons C.N., Rustad T.R., Bowden R.A., White T.C. Rapid, transient fluconazole resistance in Candida albicans is associated with increased mRNA levels of CDR. Antimicrobial Agents and Chemotherapy 1998, 42:2584-2589.
42. Selmecki A., Forche A., Berman J. Aneuploidy and isochromosome formation in drug-resistant Candida albicans. Science 2006, 313:367-370.
43. Hickman M.A., Zeng G., Forche A., Hirakawa M.P., Abbey D., Harrison B.D., et al. The 'obligate diploid' Candida albicans forms mating-competent haploids. Nature 2013, 10.1038/nature11865.
44. Idnurm A. A tetrad analysis of the basidiomycete fungus Cryptococcus neoformans. Genetics 2010, 185:153-163.
45. Dromer F., Varma A., Ronin O., Mathoulin S., Dupont B. Molecular typing of Cryptococcus neoformans serotype D clinical isolates. Journal of Clinical Microbiology 1994, 32:2364-2371.
46. Wickes B.L., Moore T.D., Kwon-Chung K.J. Comparison of the electrophoretic karyotypes and chromosomal location of ten genes in the two varieties of Cryptococcus neoformans. Microbiology 1994, 140:543-550.
47. Brandt M.E., Pfaller M.A., Hajjeh R.A., Graviss E.A., Rees J., Spitzer E.D., et al. Molecular subtypes and antifungal susceptibilities of serial Cryptococcus neoformans isolates in human immunodeficiency virus-associated Cryptococcosis, Cryptococcal Disease Active Surveillance Group. Journal of Infectious Diseases 1996, 174:812-820.
48. Fries B.C., Chen F., Currie B.P., Casadevall A. Karyotype instability in Cryptococcus neoformans infection. Journal of Clinical Microbiology 1996, 34:1531-1534.
49. Spitzer E.D., Spitzer S.G., Freundlich L.F., Casadevall A. Persistence of initial infection in recurrent Cryptococcus neoformans meningitis. Lancet 1993, 341:595-596.
50. Desnos-Ollivier M., Patel S., Spaulding A.R., Charlier C., Garcia-Hermoso D., Nielsen K., et al. Mixed infections and in vivo evolution in the human fungal pathogen Cryptococcus neoformans. mBio 2010, 1.
51. Hu G., Wang J., Choi J., Jung W.H., Liu I., Litvintseva A.P., et al. Variation in chromosome copy number influences the virulence of Cryptococcus neoformans and occurs in isolates from AIDS patients. BMC Genomics 2011, 12:526.
52. Mondon P., Petter R., Amalfitano G., Luzzati R., Concia E., Polacheck I., et al. Heteroresistance to fluconazole and voriconazole in Cryptococcus neoformans. Antimicrobial Agents and Chemotherapy 1999, 43:1856-1861.
53. Xu J., Onyewu C., Yoell H.J., Ali R.Y., Vilgalys R.J., Mitchell T.G. Dynamic and heterogeneous mutations to fluconazole resistance in Cryptococcus neoformans. Antimicrobial Agents and Chemotherapy 2001, 45:420-427.
54. Yamazumi T., Pfaller M.A., Messer S.A., Houston A.K., Boyken L., Hollis R.J., et al. Characterization of heteroresistance to fluconazole among clinical isolates of Cryptococcus neoformans. Journal of Clinical Microbiology 2003, 41:267-272.
55. Sionov E., Chang Y.C., Garraffo H.M., Kwon-Chung K.J. Heteroresistance to fluconazole in Cryptococcus neoformans is intrinsic and associated with virulence. Antimicrobial Agents and Chemotherapy 2009, 53:2804-2815.
56. Sionov E., Lee H., Chang Y.C., Kwon-Chung K.J. Cryptococcus neoformans overcomes stress of azole drugs by formation of disomy in specific multiple chromosomes. PLoS Pathogens 2010, 6:e1000848.
57. Ngamskulrungroj P., Chang Y., Hansen B., Bugge C., Fischer E., Kwon-Chung K.J. Characterization of the chromosome 4 genes that affect fluconazole-induced disomy formation in Cryptococcus neoformans. PLoS One 2012, 7:e33022.
58. Ngamskulrungroj P., Chang Y., Hansen B., Bugge C., Fischer E., Kwon-Chung K.J. Cryptococcus neoformans Yop1, an endoplasmic reticulum curvature-stabilizing protein, participates with Sey1 in influencing fluconazole-induced disomy formation. FEMS Yeast Research 2012, 12:748-754.
59. English A.R., Zurek N., Voeltz G.K. Peripheral ER structure and function. Current Opinion in Cell Biology 2009, 21:596-602.
60. Hartwell L.H., Dutcher S.K., Wood J.S., Garvik B. The fidelity of mitotic chromosome reproduction in Saccharomyces cerevisiae. Proceedings of the Berkeley workshop on recent advances in yeast molecular biology and recombinant DNA 1982, 28-38. University of California, Berkeley, CA.
61. Semighini C.P., Averette A.F., Perfect J.R., Heitman J. Deletion of Cryptococcus neoformans AIF ortholog promotes chromosome aneuploidy and fluconazole-resistance in a metacaspase-independent manner. PLoS Pathogens 2011, 7:e1002364.
62. Cruickshank J.G., Cavill R., Jelbert M. Cryptococcus neoformans of unusual morphology. Applied Microbiology 1973, 25:309-312.
63. Feldmesser M., Kress Y., Casadevall A. Dynamic changes in the morphology of Cryptococcus neoformans during murine pulmonary infection. Microbiology 2001, 147:2355-2365.
64. Zaragoza O., Garcia-Rodas R., Nosanchuk J.D., Cuenca-Estrella M., Rodriguez-Tudela J.L., Casadevall A. Fungal cell gigantism during mammalian infection. PLoS Pathogens 2010, 6:e1000945.
65. Okagaki L.H., Strain A.K., Nielsen J.N., Charlier C., Baltes N.J., Chretien F., et al. Cryptococcal cell morphology affects host cell interactions and pathogenicity. PLoS Pathogens 2010, 6:e1000953.
66. Chrisman C.J., Albuquerque P., Guimaraes A.J., Nieves E., Casadevall A. Phospholipids trigger Cryptococcus neoformans capsular enlargement during interactions with amoebae and macrophages. PLoS Pathogens 2011, 7:e1002047.
67. Zaragoza O. Multiple disguises for the same party: the concepts of morphogenesis and phenotypic variations in Cryptococcus neoformans. Frontiers in Microbiology 2011, 2:181.
68. Lengeler K.B., Cox G.M., Heitman J. Serotype AD strains of Cryptococcus neoformans are diploid or aneuploid and are heterozygous at the mating-type locus. Infection and Immunity 2001, 69:115-122.
69. Lin X., Litvintseva A.P., Nielsen K., Patel S., Floyd A., Mitchell T.G., et al. alpha AD alpha hybrids of Cryptococcus neoformans: evidence of same-sex mating in nature and hybrid fitness. PLoS Genetics 2007, 3:1975-1990.
70. Litvintseva A.P., Lin X., Templeton I., Heitman J., Mitchell T.G. Many globally isolated AD hybrid strains of Cryptococcus neoformans originated in Africa. PLoS Pathogens 2007, 3:1109-1117.
71. Lin X., Nielsen K., Patel S., Heitman J. Impact of mating type, serotype, and ploidy on the virulence of Cryptococcus neoformans. Infection and Immunity 2008, 76:2923-2938.
72. Barchiesi F., Cogliati M., Esposto M.C., Spreghini E., Schimizzi A.M., Wickes B.L., et al. Comparative analysis of pathogenicity of Cryptococcus neoformans serotypes A, D and AD in murine cryptococcosis. Journal of Infection 2005, 51:10-16.
73. Lin X., Patel S., Litvintseva A.P., Floyd A., Mitchell T.G., Heitman J. Diploids in the Cryptococcus neoformans serotype A population homozygous for the alpha mating type originate via unisexual mating. PLoS Pathogens 2009, 5:e1000283.
74. Li W., Averette A.F., Desnos-Ollivier M., Ni M., Dromer F., Heitman J. Genetic diversity and genomic plasticity of Cryptococcus neoformans AD hybrid strains. G3 (Bethesda) 2012, 2:83-97.
75. Viviani M.A., Cogliati M., Esposto M.C., Lemmer K., Tintelnot K., Colom Valiente M.F., et al. Molecular analysis of 311 Cryptococcus neoformans isolates from a 30-month ECMM survey of cryptococcosis in Europe. FEMS Yeast Research 2006, 6:614-619.
76. Kvitek D.J., Will J.L., Gasch A.P. Variations in stress sensitivity and genomic expression in diverse S. cerevisiae isolates. PLoS Genetics 2008, 4:e1000223.
77. Borneman A.R., Desany B.A., Riches D., Affourtit J.P., Forgan A.H., Pretorius I.S., et al. Whole-genome comparison reveals novel genetic elements that characterize the genome of industrial strains of Saccharomyces cerevisiae. PLoS Genetics 2011, 7:e1001287.
78. Chen G., Bradford W.D., Seidel C.W., Li R. Hsp90 stress potentiates rapid cellular adaptation through induction of aneuploidy. Nature 2012, 482:246-250.
79. Sheltzer J.M., Blank H.M., Pfau S.J., Tange Y., George B.M., Humpton T.J., et al. Aneuploidy drives genomic instability in yeast. Science 2011, 333:1026-1030.
80. Storchova Z., Breneman A., Cande J., Dunn J., Burbank K., O'Toole E., et al. Genome-wide genetic analysis of polyploidy in yeast. Nature 2006, 443:541-547.
81. Storchova Z., Kuffer C. The consequences of tetraploidy and aneuploidy. Journal of Cell Science 2008, 121:3859-3866.
82. Upender M.B., Habermann J.K., McShane L.M., Korn E.L., Barrett J.C., Difilippantonio M.J., et al. Chromosome transfer induced aneuploidy results in complex dysregulation of the cellular transcriptome in immortalized and cancer cells. Cancer Research 2004, 64:6941-6949.
83. Williams B.R., Prabhu V.R., Hunter K.E., Glazier C.M., Whittaker C.A., Housman D.E., et al. Aneuploidy affects proliferation and spontaneous immortalization in mammalian cells. Science 2008, 322:703-709.
84. Weaver B.A., Cleveland D.W. Does aneuploidy cause cancer?. Current Opinion in Cell Biology 2006, 18:658-667.
85. Cahill D.P., Lengauer C., Yu J., Riggins G.J., Willson J.K., Markowitz S.D., et al. Mutations of mitotic checkpoint genes in human cancers. Nature 1998, 392:300-303.
86. Li M., Fang X., Baker D.J., Guo L., Gao X., Wei Z., et al. The ATM-p53 pathway suppresses aneuploidy-induced tumorigenesis. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:14188-14193.
87. Bunz F., Fauth C., Speicher M.R., Dutriaux A., Sedivy J.M., Kinzler K.W., et al. Targeted inactivation of p53 in human cells does not result in aneuploidy. Cancer Research 2002, 62:1129-1133.
88. Sotillo R., Hernando E., Diaz-Rodriguez E., Teruya-Feldstein J., Cordon-Cardo C., Lowe S.W., et al. Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell 2007, 11:9-23.
89. Torres E.M., Dephoure N., Panneerselvam A., Tucker C.M., Whittaker C.A., Gygi S.P., et al. Identification of aneuploidy-tolerating mutations. Cell 2010, 143:71-83.
90. Fujiwara T., Bandi M., Nitta M., Ivanova E.V., Bronson R.T., Pellman D. Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature 2005, 437:1043-1047.
91. Duncan A.W., Taylor M.H., Hickey R.D., Hanlon Newell A.E., Lenzi M.L., Olson S.B., et al. The ploidy conveyor of mature hepatocytes as a source of genetic variation. Nature 2010, 467:707-710.
92. Duncan A.W., Hanlon Newell A.E., Bi W., Finegold M.J., Olson S.B., Beaudet A.L., et al. Aneuploidy as a mechanism for stress-induced liver adaptation. Journal of Clinical Investigation 2012, 122:3307-3315.
93. Pavelka N., Rancati G., Li R. Dr Jekyll and Mr Hyde: role of aneuploidy in cellular adaptation and cancer. Current Opinion in Cell Biology 2010, 22:809-815.
94. Capp J.P. Noise-driven heterogeneity in the rate of genetic-variant generation as a basis for evolvability. Genetics 2010, 185:395-404.
95. Lemoine F.J., Degtyareva N.P., Lobachev K., Petes T.D. Chromosomal translocations in yeast induced by low levels of DNA polymerase a model for chromosome fragile sites. Cell 2005, 120:587-598.
96. Torres E.M., Sokolsky T., Tucker C.M., Chan L.Y., Boselli M., Dunham M.J., et al. Effects of aneuploidy on cellular physiology and cell division in haploid yeast. Science 2007, 317:916-924.
97. Tang Y.C., Williams B.R., Siegel J.J., Amon A. Identification of aneuploidy-selective antiproliferation compounds. Cell 2011, 144:499-512.
98. Quintyne N.J., Reing J.E., Hoffelder D.R., Gollin S.M., Saunders W.S. Spindle multipolarity is prevented by centrosomal clustering. Science 2005, 307:127-129.
99. Kwon M., Godinho S.A., Chandhok N.S., Ganem N.J., Azioune A., Thery M., et al. Mechanisms to suppress multipolar divisions in cancer cells with extra centrosomes. Genes and Development 2008, 22:2189-2203.